The Only Event Dedicated to Optimizing ADC Process Development & Accelerating Manufacturing to Stay Ahead of Shortening Timeframes
As the ADC industry grow more competitive and manufacturing timelines get shorter, don’t let your processes hold you back.
With more ADC programs entering the clinic and commercial focus intensifying, the 3rd ADC Process Development Summit returned to spotlight the process innovations needed to deliver high-quality ADCs efficiently and reliably.
Providing a technical program built for experts in process development, CMC, manufacturing, and regulatory strategy, this was the only ADC meeting taking a deep dive into the operational details. From bioconjugation and purification to technology transfer and drug product scale-up, you got the insights to streamline your processes and deliver more homogenous and high-quality ADCs faster.
“I am excited to engage with colleagues from diverse functions and backgrounds, exchanging insights into the latest advancements in ADC process development. Together, by sharing our expertise and fostering collaboration, we can enhance the ADC pipeline and ensure the continued safety and well-being of patients worldwide”
Laurencia Zongo, Scientist, Purification Process Sciences, AstraZeneca
Expert Speaker, 2025
What You Missed:
Overcoming impurity challenges by exploring new methods to identify, characterize, and control process-related variants and degradation products with Northeastern University
Defining CQA-driven specifications to guide phase-appropriate process development and accelerate tech transfer with ADC Therapeutics and AstraZeneca
Advancing drug product development by tackling dosage form and SKU considerations, rapid lyophilization cycle development, and comparability strategies with AbbVie and Exelixis
Discussing single-use vs. stainless steel equipment choices for conjugation, purification, and scale-up in dedicated roundtables with CDMO and process leaders
Aligning process development with regulatory CMC expectations to balance early-phase flexibility with compliant strategies, with Merck and leading regulatory experts
New Speaking Companies for 2025 Included:
